Bimekizumab in patients with moderate to severe plaque psoriasis by bodyweight: Pooled results from phase 3 trials. J of Skin [Internet]. 2022 Nov. 16 [cited 2025 Oct. 6];6(6):s73. Available from: https://skin.dermsquared.com/skin/article/view/1830